Skip to main content

Year: 2020

Field Trip Health Ltd. Schedules Second Fiscal Quarter 2021 Financial Results Conference Call for Tuesday, December 1, 2020 at 8:00 am ET

TORONTO, Nov. 25, 2020 (GLOBE NEWSWIRE) — Field Trip Health Ltd. (CSE: FTRP, OTCBB: FTRPF) (“Field Trip”), a global leader in the development and delivery of psychedelic therapies, announced today that it plans to release financial results for its second fiscal quarter ended September 30, 2020, after market close on Monday, November 30, 2020.The Company will conduct a conference call and webcast to review its results the following day, Tuesday, December 1, 2020 at 8:00 am ET. To access the call, please dial 1-877-407-9716 or 1-201-493-6779 and provide conference ID 13713475. A live webcast of the conference call can be accessed via the Events and Presentations section of the Field Trip Health Investor Relations website or via the following link: http://public.viavid.com/index.php?id=142525.For those unable to attend...

Continue reading

ParcelPal Announces its First Profitable Month in the History of the Company

VANCOUVER, British Columbia, Nov. 25, 2020 (GLOBE NEWSWIRE) — ParcelPal Technology Inc. (“ParcelPal” or the “Company”), (PKG:CSE) (FSE:PT0) (OTC:PTNYF) is pleased to announce that for the month of October 2020, it turned its first profit in the history of the Company.  CEO Rich Wheeless stated, “This is a major milestone for the Company and I believe also a turning point for us. This has also been a personal mission of mine since the day the board promoted me to CEO in April, and while no one can guarantee every month to be a profitable one, this remains a significant positive event for our Company. A combination of cost cutting measures (right sizing the business), signing more profitable contracts, moving into new industries and markets and a renewed focus on what the company does best has led to this and has additionally strengthened...

Continue reading

NexTech AR Subsidiary, Map Dynamics, Hosts Houston Ballet’s 2020 Virtual Nutcracker Market

VANCOUVER British Columbia and HOUSTON, Nov. 25, 2020 (GLOBE NEWSWIRE) — NexTech AR Solutions (NexTech) (OTCQB: NEXCF) (CSE: NTAR) (FSE: N29), a leading provider of virtual and augmented reality (AR) experience technologies and services for virtual and hybrid eCommerce, education, conferences and events today provided an update from subsidiary Map Dynamics on the first virtual event it’s hosting under the NexTech brand: Houston Ballet’s Virtual Nutcracker Market. During the 2019 Nutcracker Market, over 107,240 customers spent over $20.4 million.The 2020 Virtual Nutcracker Market, launched on November 11, features 150 exhibitors representing apparel, beauty, food, home decor and more, many of whom are small businesses based or operating within the local Houston, Texas market. To date, the 2020 Nutcracker Market has drawn 716,823...

Continue reading

Radient Technologies Announces partnership with US based Dreamy CBD

Radient launches foray into the CBD market through exclusive rights to Dreamy CBD brandsEDMONTON, Alberta, Nov. 25, 2020 (GLOBE NEWSWIRE) — Radient Technologies Inc. (“Radient” or the “Company”) (TSX Venture: RTI; OTCQX: RDDTF), is pleased to announce a licensing agreement with Dreamy Co., (“Dreamy”) to bring in Dreamy CBD products under Radient’s platform to Canada and extend it to other international markets. Initially founded in the US, Dreamy has developed a lifestyle brand over the past decade focused on the Health and Wellness space before branching into the CBD vertical. Dreamy is focused on creating and inspiring people to use plant medicine and holistic healing in place of conventional pharmaceutical solutions. In the US, Dreamy CBD enjoys a strong presence in California, and the Dreamy brand has a strong association with...

Continue reading

AnPac Bio Sets Record Test Volume in Q3, and Forecasts ~ 100% Revenue Growth in 2020

SAN JOSE, Calif., Nov. 25, 2020 (GLOBE NEWSWIRE) — AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the United States focused on early cancer screening and detection, announced today that it experienced strong demand for its cancer screening tests and set a record in paid test volume in the third quarter. With a strong fourth quarter already underway, the Company forecasts a revenue growth of approximately 100% in 2020 over 2019, with a revenue range of US$3 million (~ RMB20 million) to US$3.3 million (~ RMB22 million). For 2019, the Company had a revenue of US$1.6 million (~ RMB10.9 million) (using a current US$ to RMB exchange ratio of ~ 6.6). We expect the strong momentum of YoY revenue growth due to market demand and customers accepting...

Continue reading

Maha Energy AB (publ) (“Maha” or the “Company”) nomination committee for the AGM 2021

In accordance with the resolution at the Annual General Meeting (“AGM”) of Maha Energy AB on May 27, 2020, it was resolved that a Nomination Committee shall be appointed. The Nomination Committee shall comprise of the Chairman of the Board of Directors and three members appointed by the three largest shareholders by votes at the end of September each year.On September 30, 2020, the three largest shareholders, which desired to appoint a representative to the Nomination Committee, were; Kvalitena AB, Jonas Lindvall and Ronald Panchuk. Each such shareholder has appointed a representative, as shown below, who together with the Chairman of the Board of Directors will form the Company’s Nomination Committee.The Nomination Committee’s members are:Jonas Vestin, appointed by Kvalitena ABHenrik Morén, appointed by Jonas Lindvall.Ronald Panchuk...

Continue reading

Marimaca Copper Receives Final Documentation for Upcoming Drilling Program

VANCOUVER, British Columbia, Nov. 25, 2020 (GLOBE NEWSWIRE) — Marimaca Copper Corp. (“Marimaca Copper” or the “Company”) (TSX: MARI) is pleased to announce that, following the positive vote by the Antofagasta Environmental Evaluation Commission (refer to news release on 5 November 2020), it has received its Environmental Qualification Resolution (“RCA”), which allows it to undertake new exploration campaigns at the Marimaca Copper Project (the “Project”) and in the broader Marimaca District.HighlightsFinal RCA received from the Environmental Assessment Service completes the thorough permitting process for the CompanyEvaluation process demonstrates that the Company and the Project, including its surrounding areas, comply with all environmental regulationsApprovals granted for the construction of up to 365 drill pads over the next...

Continue reading

Acarix receives US market approval for the CADScor® System

Press release (MAR)Malmö, Sweden November 25, 2020Acarix receives US market approval for the CADScor® SystemAcarix AB (publ) today announced that the US Food and Drug Administration (FDA) has approved the company’s De Novo application for marketing approval of the CADScor®System in the US.“This is a major achievement and a significant recognition of our technology and how it can improve the diagnosis of patients with potential Coronary Artery Disease”. “In addition, it will contribute significantly to the value creation of Acarix. This approval enables us to take all measures to prepare the market launch in the USA.” said Per Persson, CEO of Acarix”.The De Novo process is used for new products where there is no predicate device with a comparable indication in the US market to support a standard 510 (k) application. Acarix filed the De...

Continue reading

Acarix erhåller marknadsgodkännande för CADScor® System för försäljning på den amerikanska marknaden

Pressmeddelande (MAR)Malmö, Sverige, 25 november 2020Acarix erhåller marknadsgodkännande för CADScor®  System för försäljning på den amerikanska marknadenAcarix AB (publ) meddelade idag att det amerikanska läkemedelsverket (FDA) har godkänt bolagets De Novo ansökan för ett marknadsföringsgodkännande för CADScor®System i USA.”Detta är en fenomenal prestation och ett enormt erkännande av vår teknologi och CADScor® Systems möjlighet att förbättra den diagnostiska processen för potentiella CAD-patienter i USA. Dessutom kommer markandsgodkännandet att bidra betydligt i det fortsatta värdeskapandet av Acarix och gör det nu möjligt för oss att vidta alla åtgärder som krävs i förberedelserna för en lansering i USA.” säger Per Persson, vd för Acarix.De Novo-processen används för nya produkter där det inte finns någon direkt jämförbar produkt med...

Continue reading

Korrigenda: EPH European Property Holdings Ltd announces plans to issue and offer up to 4,500,000 new ordinary shares for USD 36.82 per share

25 November 2020, Road Town, Tortola, BVIEPH European Property Holdings Ltd (the “Company”), an investment company listed on SIX Swiss Exchange which holds an extensive property portfolio with a total value of around USD 1.3 billion across Europe, announces its intention to issue and offer up to 4,500,000 new ordinary shares for a consideration equaling the last reported net asset value (as per 30 June 2020) in the amount of USD 36.82 per share (the “Offer Shares”).EPH will hold a virtual conference on Monday, 30 November 2020 at 3 pm CET to explain details of the capital increase and the company’s strategy. You are welcome to register for this event. Please contact corporatefinance@valartis.ch to receive dial-in data.The proceeds from the issue of the Offer Shares will be used for funding our future growth...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.